FONT-SIZE Plus   Neg

FDA Posts Briefing Documents For Advisory Committee Meeting Reviewing Gattex

NPS Pharmaceuticals, Inc. (NPSP) announced that the U.S. Food and Drug Administration, or FDA, has posted briefing materials for the October 16, 2012 Gastrointestinal Drugs Advisory Committee meeting to review Gattex (teduglutide).

Gattex is a new, recombinant analog of human glucagon-like peptide 2 (a protein involved in the rehabilitation of the intestinal lining) being developed for the treatment of adults with short bowel syndrome.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
T-Mobile US Inc. on Monday lifted its forecast for fiscal 2016 adjusted EBITA, a key earnings metric, as well as customer additions after reporting a surge in third-quarter profit and and revenues with strong customer growth. Earnings per share came in above market estimates. In pre-market activity, shares were gaining around 4.8 percent to $49. Shares of Philips Electronics NV were gaining around 3 percent in the early morning trading in Amsterdam after the Dutch consumer electronics giant reported Monday a higher profit in its third quarter driven by margin strength with improved performance in its segments. Consolidated comparable sales growth was 2 percent, driven by 5 percent increase in HealthTech portfolio. AT&T announced a definitive agreement to purchase Time Warner in a stock-and-cash transaction valued at $107.50 per share. This purchase price implies a total equity value of $85.4 billion and a total transaction value of $108.7 billion, including Time Warner's net debt. AT&T expects the deal to close before year-end 2017.
comments powered by Disqus
Follow RTT